Vida Stegel

430 total citations
36 papers, 334 citations indexed

About

Vida Stegel is a scholar working on Genetics, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Vida Stegel has authored 36 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 15 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Vida Stegel's work include BRCA gene mutations in cancer (16 papers), Genetic factors in colorectal cancer (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Vida Stegel is often cited by papers focused on BRCA gene mutations in cancer (16 papers), Genetic factors in colorectal cancer (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). Vida Stegel collaborates with scholars based in Slovenia, United States and Italy. Vida Stegel's co-authors include Srdjan Novaković, Marko Hočevar, Mateja Krajc, Janez Žgajnar, Ksenija Geršak, Barbara Jezeršek Novaković, Nikola Bešič, Barbara Gazić, Ana Blatnik and Alojz Ihan and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Vaccine.

In The Last Decade

Vida Stegel

34 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vida Stegel Slovenia 11 143 135 87 75 56 36 334
Kyren A. Lazarus Australia 10 201 1.4× 153 1.1× 62 0.7× 95 1.3× 22 0.4× 14 413
Sven Ackermann Germany 8 106 0.7× 61 0.5× 95 1.1× 88 1.2× 32 0.6× 13 323
Pamela Younes United States 6 194 1.4× 160 1.2× 71 0.8× 156 2.1× 20 0.4× 14 356
Hualei Bu China 11 173 1.2× 59 0.4× 91 1.0× 118 1.6× 34 0.6× 24 354
Petra Zemánková Czechia 10 149 1.0× 117 0.9× 97 1.1× 106 1.4× 72 1.3× 23 308
Zhenjian Cai United States 9 133 0.9× 56 0.4× 39 0.4× 92 1.2× 49 0.9× 26 302
Inbal Kedar Israel 15 120 0.8× 155 1.1× 67 0.8× 76 1.0× 108 1.9× 42 383
Katherine V. Clark-Knowles Canada 8 161 1.1× 91 0.7× 72 0.8× 106 1.4× 44 0.8× 13 359
T Schneider Netherlands 8 94 0.7× 70 0.5× 26 0.3× 123 1.6× 35 0.6× 14 417
Stephanie A. Bien United States 9 119 0.8× 79 0.6× 65 0.7× 90 1.2× 86 1.5× 15 284

Countries citing papers authored by Vida Stegel

Since Specialization
Citations

This map shows the geographic impact of Vida Stegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vida Stegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vida Stegel more than expected).

Fields of papers citing papers by Vida Stegel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vida Stegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vida Stegel. The network helps show where Vida Stegel may publish in the future.

Co-authorship network of co-authors of Vida Stegel

This figure shows the co-authorship network connecting the top 25 collaborators of Vida Stegel. A scholar is included among the top collaborators of Vida Stegel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vida Stegel. Vida Stegel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Blatnik, Ana, Vida Stegel, Srdjan Novaković, et al.. (2023). A Population-Based Study of Patients With Small Cell Carcinoma of the Ovary, Hypercalcemic Type, Encompassing a 30-Year Period. Archives of Pathology & Laboratory Medicine. 148(3). 299–309. 5 indexed citations
3.
4.
Novaković, Srdjan, Vida Stegel, Barbara Gazić, et al.. (2020). The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients – Slovenian population based study. Radiology and Oncology. 54(2). 180–186. 3 indexed citations
5.
Krajc, Mateja, Ana Blatnik, Vida Stegel, et al.. (2020). Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients. Annals of Surgical Oncology. 28(5). 2561–2570. 10 indexed citations
6.
Gašljević, Gorana, et al.. (2020). An interesting case of likely BRCA2 related bilateral breast cancer with metastasis in the fimbrial part of fallopian tube. Hereditary Cancer in Clinical Practice. 18(1). 7–7. 1 indexed citations
7.
Hošnjak, Lea, Vida Stegel, Srdjan Novaković, et al.. (2020). Risk factors for the development of high‐grade dysplasia and carcinoma in patients with laryngeal squamous cell papillomas: Large retrospective cohort study. Head & Neck. 43(3). 956–966. 7 indexed citations
8.
Novaković, Srdjan, Vida Stegel, Marko Hočevar, et al.. (2019). Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1/2 genes in patients with tubo-ovarian high grade serous carcinoma. BMC Cancer. 19(1). 296–296. 24 indexed citations
9.
Krivokuća, Ana, Ljiljana Stamatović, Ana Blatnik, et al.. (2017). Novel BRCA1 splice-site mutation in ovarian cancer patients of Slavic origin. Familial Cancer. 17(2). 179–185. 6 indexed citations
10.
11.
12.
Krajc, Mateja, Vesna Zadnik, Srdjan Novaković, et al.. (2013). Geographical distribution of Slovenian BRCA1/2 families according to family origin: implications for genetic screening. Clinical Genetics. 85(1). 59–63. 12 indexed citations
13.
14.
Novaković, Srdjan, et al.. (2012). Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families. International Journal of Oncology. 41(5). 1619–1627. 23 indexed citations
15.
Novaković, Srdjan, et al.. (2011). Genotyping of BRCA1, BRCA2, p53, CDKN2A, MLH1 and MSH2 genes in a male patient with secondary breast cancer. Radiology and Oncology. 45(4). 296–9. 5 indexed citations
16.
Novaković, Barbara Jezeršek, et al.. (2010). Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity. BMC Immunology. 11(1). 45–45. 12 indexed citations
17.
Novaković, Srdjan, Vida Stegel, Andreja Nataša Kopitar, Alojz Ihan, & Barbara Jezeršek Novaković. (2007). Preventive and therapeutic antitumor effect of tumor vaccine composed of CpG ODN class C and irradiated tumor cells is triggered through the APCs and activation of CTLs. Vaccine. 25(49). 8241–8256. 17 indexed citations
18.
Kopitar, Andreja Nataša, Vida Stegel, Bojan Tepeš, et al.. (2006). Specific T cell responses to Helicobacter pylori predict successful eradication therapy. Journal of Infection. 54(3). 257–261. 13 indexed citations
19.
Novaković, Srdjan & Vida Stegel. (2005). Rapid detection of most frequent Slovenian germ-line mutations in BRCA1 gene using real-time PCR and melting curve analysis. Radiology and Oncology. 39(2). 2 indexed citations
20.
Stegel, Vida, Andreja Nataša Kopitar, Barbara Jezeršek Novaković, Alojz Ihan, & Srdjan Novaković. (2005). Dendritic cells incubated with irradiated tumor cells effectively stimulate T lymphocyte activation and induce enhanced expression of CD69, CD25 as well as production of IFNγ and IL4. International Immunopharmacology. 6(1). 79–89. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyren A. Lazarus Breakdown of academic impact, for papers by Sven Ackermann Breakdown of academic impact, for papers by Pamela Younes Breakdown of academic impact, for papers by Hualei Bu Breakdown of academic impact, for papers by Petra Zemánková Breakdown of academic impact, for papers by Zhenjian Cai Breakdown of academic impact, for papers by Inbal Kedar Breakdown of academic impact, for papers by Katherine V. Clark-Knowles Breakdown of academic impact, for papers by T Schneider Breakdown of academic impact, for papers by Stephanie A. Bien
Rankless by CCL
2026